Merck
MRK
#43
Rank
NZ$610.52 B
Marketcap
NZ$247.46
Share price
-0.54%
Change (1 day)
73.13%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): NZ$6.00

According to Merck's latest financial reports the company's current EPS (TTM) is NZ$6.15. In 2025 the company made an earnings per share (EPS) of NZ$12.57 an increase over its 2024 EPS that were of NZ$11.62.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.00-52.26%
2025NZ$12.578.15%
2024NZ$11.624308.46%
2023NZ$0.26-97.32%
2022NZ$9.8510.92%
2021NZ$8.8884.68%
2020NZ$4.81-27.2%
2019NZ$6.6163.44%
2018NZ$4.04151.11%
2017NZ$1.61-54.58%
2016NZ$3.5430.21%
2015NZ$2.72-61.99%
2014NZ$7.16180.51%
2013NZ$2.55-31.82%
2012NZ$3.746.62%
2011NZ$3.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.02 144.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.07 96.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.25-63.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.20 0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.53 689.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.90 305.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.40-28.40%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$6.12-0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.68 8.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.36-61.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel